A report in The New Scientist, "Prescribing of Hyperactivity Drugs is Out of Control," shows just how deviant U.S. prescribing of psychostimulants for
children is compared to the rest of the world. Continue reading →
Modafinil
Addictive Qualities of Modafinil Not Discussed by FDA Advisory
The focus of a recent FDA’s Psychopharmacology Advisory Committee meeting, was the drug, modafinil (as Sparlon), for ADHD and the risk of
Steven-Johnson’s, a rare but potentially fatal, skin condition.
“Some of the children were prescribed anti-psychotics, rather than discontinued from ADHD therapy.”
"That thing I’m worried about…where the MedGuide would help, where it might even warrant a black box, if this is common, where somebody hallucinates and then gets put on an anti-psychotic drug. That would really be something worth making sure it doesn’t happen,"
Continue reading →
The Ball is in their court–Is FDA preparing to drop it?
On Wednesday, the FDA Pediatric Advisory Committee handed the agency a mixed message regarding warnings about selective list of
psychotropic drugs prescribed for treating ADHD symptoms. Continue reading →
2.5 Million US Children Prescribed Antipsychotics_ FDA ADHD–ADR Review
The Associated Press reports that a just released study that found that a staggering, two and half million children in the U.S. are being prescribed antipsychotics annually–that’s 40 out of every 1,000 children.
Continue reading →
FDA Review ADHD Drugs Induce-Psychosis, Mania, Homicide, Suicide
Psychiatric Adverse Events Associated with Drug Treatment of ADHD: Review of Postmarketing Safety Data Continue reading →
Which is it—51 or 186 deaths linked to ADHD drugs?
Children have been dying from exposure to psychostimulant drugs as the FDA looked the other way: